home / stock / auph / auph news


AUPH News and Press, Aurinia Pharmaceuticals Inc From 08/06/21

Stock Information

Company Name: Aurinia Pharmaceuticals Inc
Stock Symbol: AUPH
Market: NASDAQ
Website: auriniapharma.com

Menu

AUPH AUPH Quote AUPH Short AUPH News AUPH Articles AUPH Message Board
Get AUPH Alerts

News, Short Squeeze, Breakout and More Instantly...

AUPH - HIMX, ORMP AND BITF among pre market gainers

Sphere 3D Corp (NASDAQ:ANY) +43% agreement to acquire exclusive rights for assignment of cryptocurrency mining assets Kaixin Auto (NASDAQ:KXIN) +23% on foraying into new energy vehicle business Switch (NYSE:SWCH) +19% on Q2 earnings Westport Fuel (NASDAQ:WPRT) +1...

AUPH - Aurinia Pharma extends gains on following robust Q2 top-line growth

Aurinia Pharmaceuticals (NASDAQ:AUPH) continues its yesterday's post-market rally and is up 14.7% premarket after it reported financial results for Q2 ended June 30, 2021. The company recorded robust revenue growth of 624% to $6.6M over prior quarter, ahead of analyst estimate of $5...

AUPH - Aurinia Pharmaceuticals Inc. (AUPH) CEO John Leonard on Q2 2021 Results - Earnings Call Transcript

Aurinia Pharmaceuticals Inc. (AUPH) Q2 2021 Earnings Conference Call August 5, 2021 16:30 ET Company Participants Glenn Schulman - Senior Vice President of Corporate Communications & Investor Relations Peter Greenleaf - President & Chief Executive Officer Joe Miller - Chief Financial ...

AUPH - Aurinia Pharma EPS misses by $0.01, beats on revenue

Aurinia Pharma (NASDAQ:AUPH): Q2 GAAP EPS of -$0.37 misses by $0.01. Revenue of $6.62M (+21966.7% Y/Y) beats by $1.66M. Gross margin for the three and six months ended June 30, 2021 was ~95%. “As we continue to expand patient access to LUPKYNIS across the United States, we anticip...

AUPH - Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights

– $6.6 million in net revenue for the second quarter 2021 (624% increase from first quarter 2021) – – 415 patient start forms (PSFs) received for LUPKYNIS™ during the second quarter (over a 60% increase from the first quarter 2021) and over 800 PSFs recei...

AUPH - 4 Canadian Stocks to Buy This Week

Earnings season continues for Motley Fool investors this week. There are still plenty of great Canadian stocks to buy before a quick boost from hopefully strong earnings. So, here are four I would consider watching as earnings come out August 5 and even buying ahead of time for a quick litt...

AUPH - Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that it will release its second quarter 2021 financial results on Thursday, August 5, 2021, after the markets close. Aurinia’s management team will also host a conference call at ...

AUPH - Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company), a commercial stage biopharmaceutical company advancing therapies for severe autoimmune diseases, announced today it will voluntarily delist the common shares of the Company from the Toronto Stock Exchan...

AUPH - My 3 Favourite TSX Stocks Today

Investors continue to be hungry for growth after the insane amount we saw in 2020 from TSX stocks. After a huge crash and a pandemic to boot, Canadians learned to save — a lot . In fact, analysts have stated that, on average, Canadians saved more in the last year than they ha...

AUPH - 3 Dirt-Cheap TSX Stocks to Buy Now

When it comes to finding cheap TSX stocks there are a few things you need to take into consideration, but not necessarily all at once. There might be a cheap share price you want to consider. There could be a future growth opportunity that makes it a discount. Or there could be a pullba...

Previous 10 Next 10